Multiple Sclerosis Update: Biogen, Sanofi, Active, Adamas and Novartis

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!! Earlier this week, Active Biotech, based in Lund, Sweden, announced that it was abandoning its neurology focus, including MS. The overall focus is on the company’s wholly-owned lead assets, laquinimod and tasquinimod. Laquinimod is an oral small molecule developed primarily for …